BRIEF published on 02/26/2025 at 01:10, 10 months 18 days ago Stabilis Solutions Reports 2024 Financial Results Financial Results Market Expansion Cash Generation LNG Solutions Clean Fueling
BRIEF published on 02/26/2025 at 01:10, 10 months 18 days ago Stabilis Solutions publie ses résultats financiers pour 2024 Résultats Financiers Génération De Trésorerie Expansion Du Marché Un Carburant Propre Solutions GNL
BRIEF published on 02/26/2025 at 00:10, 10 months 18 days ago 1933 Industries Reports Record Revenue for Fiscal 2024 Financial Results Revenue Growth Cannabis Market Nevada 1933 Industries
BRIEF published on 02/26/2025 at 00:10, 10 months 18 days ago 1933 Industries annonce un chiffre d'affaires record pour l'exercice 2024 Résultats Financiers Nevada Croissance Des Revenus Marché Du Cannabis 1933 Industries
BRIEF published on 02/26/2025 at 00:05, 10 months 18 days ago MedMira Partners with Trimedic for Canadian Market Expansion MedMira Medical Diagnostics Canada Market Trimedic HIV Testing
BRIEF published on 02/26/2025 at 00:05, 10 months 18 days ago MedMira s'associe à Trimedic pour étendre son marché canadien Marché Canadien MedMira Diagnostic Médical Trimedic Dépistage Du VIH
BRIEF published on 02/25/2025 at 23:40, 10 months 18 days ago Pinetree Capital Reports Strong Financial Results for 2024 Book Value Per Share Asset Growth 2024 Financial Results Pinetree Capital Net Investment Gains
BRIEF published on 02/25/2025 at 23:40, 10 months 18 days ago Pinetree Capital annonce de solides résultats financiers pour 2024 Croissance Des Actifs Résultats Financiers 2024 La Capitale De Pinetree Gains Nets D'investissement Valeur Comptable Par Action
BRIEF published on 02/25/2025 at 23:08, 10 months 18 days ago FDA Accepts Application for UZEDY's Use in Treating Bipolar I Disorder FDA Approval Medincell Teva Pharmaceuticals UZEDY Bipolar I Disorder
BRIEF published on 02/25/2025 at 23:08, 10 months 18 days ago La FDA accepte la demande d'utilisation d'UZEDY dans le traitement du trouble bipolaire I Approbation De La FDA Teva Pharmaceuticals Médinecell OUZEDY Trouble Bipolaire I
Published on 01/16/2026 at 00:00, 2 hours 37 minutes ago LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP/GIP-based Obesity Therapies
Published on 01/15/2026 at 23:20, 3 hours 17 minutes ago Guanajuato Silver Closes Acquisition of Bolanitos Gold-Silver Mine
Published on 01/15/2026 at 23:15, 3 hours 22 minutes ago Drilling Resumes on The Nighthawk Gold/Silver Project, Nevada
Published on 01/15/2026 at 22:02, 4 hours 35 minutes ago Unusual Machines Announces $2.1 Million Order for Drone Components
Published on 01/15/2026 at 22:00, 4 hours 37 minutes ago Silver North Announces Brokered LIFE Private Placement for Gross Proceeds of up to C$5.0 Million
Published on 01/16/2026 at 00:30, 2 hours 7 minutes ago German Engraving Businesses Focus on Customization and Advanced Laser Technology in the New Year
Published on 01/15/2026 at 23:23, 3 hours 14 minutes ago Klöckner & Co and Worthington Steel sign business combination agreement
Published on 01/15/2026 at 23:22, 3 hours 15 minutes ago EQS-Adhoc: Klöckner & Co SE signs business combination agreement with Worthington Steel and supports voluntary public takeover offer to all shareholders
Published on 01/15/2026 at 23:20, 3 hours 17 minutes ago EQS-WpÜG: Takeover Offer / Target company: Klöckner & Co SE; Bidder: Worthington Steel GmbH
Published on 01/15/2026 at 19:43, 6 hours 53 minutes ago InVivo Group and the Founders jointly announce, as part of a review of their strategic priorities, their intention to file a public buy-out offer, followed by a squeeze-out of TERACT shares
Published on 01/15/2026 at 18:06, 8 hours 30 minutes ago SMTPC - Communiqué sur le Chiffre d'affaires du 4ème trimestre 2025
Published on 01/15/2026 at 17:57, 8 hours 40 minutes ago InVivo Group et les Fondateurs annoncent de concert, dans le cadre de l’évolution de leurs orientations stratégiques, leur intention de déposer une offre publique de retrait suivie d’un retrait obligatoire sur les titres TERACT
